Health Care after the Election

Monday, October 24, 2016 12:00 PM
Lectures and Panels
2016-2017
Wasserstein Hall, Milstein West AB (2019)
Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA

Description

:

As we approach the 2016 presidential election and change of administration, there are...

Read More

Health Law Workshop: W. Nicholson Price II

Monday, October 17, 2016 5:00 PM
Health Law Workshops
2016-2017
Hauser Hall, Room 104
Harvard Law School, 1575 Massachusetts Ave., Cambridge, MA

>Nicholson Price is an Assistant Professor at the University of Michigan School of Law, where he... Read More

U.N. Pledges To Fight Antibiotic Resistance In Historic Agreement

NPR, September 21, 2016
by Michaeleen Doucleff

[...] A recent report from the U.K. government found that antibiotic-resistant b...

Read More

​‘The Greed Is Astounding’:

Kaiser Health News, September 22, 2016

KHN Morning Briefing: Summaries of health policy coverage from major news organization

s

But He...

Read More

It’s Not Just For Kids:

Kaiser Health News, September 21, 2016
by Julie Appleby and Mary Agnes Carey

Even as the cost of EpiPens dramatically rose, so too did the number of prescriptions written for pa...

Read More

Investigation Reveals Drugmakers’ Deep Influence On Nation’s Response To Opioid Crisis

Kaiser Health News, September 19, 2016

KHN Morning Briefing: Summaries of health policy coverage from major news organization

s

The As...

Read More

U.N. To Take On Antibiotic Resistance At General Assembly

NPR, September 18, 2016
by Michael Martin, interviewing Keiji Fukuda

The U.N. General Assembly will devote an entire day to the issue of superbugs and antibiotic resista...

Read More

EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future

Journal of Law and the Biosciences, September 16, 2016
by Emily A. Largent (Student Fellow alumna)

Abstract

:

In 2014, West Africa confronted the most severe outbreak of Ebola virus disease (EVD) in...

Read More

EpiPen Maker Quietly Steers Effort That Could Protect Its Price

New York Times, September 16, 2016
by Eric Lipton and Rachel Abrams, quoting Rachel E. Sachs (Academic Fellow Alumnus)

[...] The idea being advanced is simple: If the EpiPen makes the federal preventive l...

Read More

Canada has just approved prescription heroin

Washington Post, September 13, 2016
by Alan Freeman

OTTAWA — The Canadian government has quietly approved new drug regulations that will permit do...

Read More

Hackers Release Medical Records Of U.S. Olympic Athletes

NPR, September 14, 2016
by Kelly McEvers interviewing Christie Aschwanden

[...] athletes hand over a lot of medical information to the anti-doping agency. Have there been con...

Read More

5 reasons why no one has built a better EpiPen

STAT, September 9, 2016
by Meghana Keshavan, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] But critics say Mylan has little incentive to improve EpiPens: “If you’re the...

Read More

Federal Survey Finds 119 Million Americans Use Prescription Drugs

NPR, September 8, 2016
by Richard Harris

Nearly half of all Americans over the age of 12 take prescription pain relievers, tranquilizers, sed...

Read More

How Mylan cornered the consumer epinephrine market

MedCityNews, September 8, 2016
by Pauline Bartolone, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] The New York state attorney general’s office announced Tuesday it will investigate...

Read More

Euro Drug Pricing’s Tradeoffs May Limit Appeal In US

Law360, September 8, 2016
by Dani Kass, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] Going forward, an influx of bills targeting drug prices could be introduced, but few are...

Read More

EpiPen’s Dominance Driven By Competitors’ Stumbles And Tragic Deaths

NPR, September 7, 2016
by Pauline Bartolone, quoting W. Nicholson Price II (Academic Fellow alumnus)

NPR recently called on Petrie-Flom Academic Fellow alumnus Nicholson Price to help explain how...

Read More

EpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog

Kaiser Health News, September 6, 2016
by Sydney Lupkin

Consumers and Congress members pushing for cheaper alternatives to the EpiPen and other high-priced...

Read More

On Heels Of EpiPen Outrage, Clinton Unveils Plan Targeting High Drug Prices

Kaiser Health News, September 6, 2016

KHN Morning Briefing: Summaries of health policy coverage from major news organization

s

Hillar...

Read More

Missouri law professor: Consider price controls after Epipen controversy

Missourinet, September 5, 2016
by Jason Taylor, quoting Rachel E. Sachs (Academic Fellow Alumna)

A Missouri law professor thinks Congress should consider imposing price controls on certain drugs af...

Read More

With Tough Warning Label, FDA Aims To Curb Fatal Overdoses From Mixing Opioids, Sedatives

Kaiser Health News, September 1, 2016

KHN Morning Briefing: Summaries of health policy coverage from major news organization

s

The ag...

Read More

Mylan’s sudden plans for a generic EpiPen

Modern Healthcare, Vital Signs Blog, August 31, 2016
by Adam Rubenfire, quoting Rachel E. Sachs (Academic Fellow alumna)

From the post

:

Obviously Mylan didn't want to underprice its own branded drug, but it's pos...

Read More

Mylan’s decision to make a cheaper, generic EpiPen ‘baffles’ experts

Business Insider, August 31, 2016
by Lydia Ramsey, featuring blog post by Rachel E. Sachs (Academic Fellow alumna)

From the article

:

"I and others who study these issues full time cannot understand why Mylan though...

Read More

Endpoints News Early Edition

Endpoints News, August 31, 2016
by John Carroll, featuring blog post by Rachel E. Sachs (Academic Fellow alumna)

From the email

:

Don't miss this commentary from Harvard's Rachel Sachs: 

;

I am not sho...

Read More

Drop In Teen Pregnancies Is Due To More Contraceptives, Not Less Sex

NPR, August 31, 2016
by Julie Rovner

Teen pregnancy is way down. And a study suggests that the reason is increased, and increasingly effe...

Read More

Did It Hurt Or Help? Researchers Analyze Ohio’s 2011 Abortion Law

Kaiser Health News, August 30, 2016
by Shefali Luthra

Did a law regulating drug-induced abortions keep women safe or block them from access to this proced...

Read More

Mylan’s Lower-Cost EpiPen May Not Hurt Drugmaker’s Sales Much

Bloomberg, August 29, 2016
by Cynthia Koons and Zachary Tracer, quoting Rachel E. Sachs (Academic Fellow alumna)

[...] Meanwhile, by introducing its generic, Mylan will set the market price for subsequent com...

Read More

Mylan Tries Again to Quell Pricing Outrage by Offering Generic EpiPen

New York Times, August 29, 2016
by Andrew Pollack

In its latest move to quell outrage over its price increases, the maker of the EpiPen has resor...

Read More

Behind the stealth ad campaigns for the EpiPen and other drugs

STAT News, August 29, 2016
by Rebecca Robbins

Mylan Pharmaceuticals has spent millions this year on television ads and celebrity te...

Read More

People With Obamacare Plans Filled More Prescriptions, But Had Lower Costs

Kaiser Health News, August 17, 2016
by Shefali Luthra

The 2010 health law was meant to expand insurance coverage so that Americans could get medical care...

Read More

The FDA Wants To Make It Harder To Buy And Sell Poop

BuzzFeed, August 13, 2016
by by Nidhi Subbaraman, quoting Rachel Sachs (Academic Fellow alumna)

[...] Depending on how the approval is handed down, Rebiotix could very well put outfits like OpenBi...

Read More

Finding Good Pain Treatment Is Hard. If You’re Not White, It’s Even Harder.

New York Times, August 9, 2016
by Abby Goodnough

[...] While an epidemic of prescription opioid abuse has swept across the United States, Africa...

Read More

When Pregnant Women Need Medicine, They Encounter A Void

NPR, August 8, 2016
by Rae Ellen Bichell

[...] But the CDC acknowledges that as pregnant women aren't usually included in drug safety stu...

Read More

Insurance Rules Can Hamper Recovery From Opioid Addiction

NPR, August 5, 2016
by Jake Harper

[...] The prior authorization process adds work for doctors and their staff, says Dr. Andr...

Read More

Bristol Myers: Opdivo Failed to Meet Endpoint in Key Lung-Cancer Study

Wall Street Journal, August 5, 2016
by Peter Loftus, Jonathan D. Rockoff, and Anne Steele

A cancer drug’s surprise failure in a clinical trial wiped $20 billion off Bristol-Myers...

Read More

The FDA is prohibited from going germline

Science, August 5, 2016
by I. Glenn Cohen (Faculty Director) and Eli Y. Adashi

Petrie-Flom Faculty Director I. Glenn Cohen has co-authored a new article in Science magazine&n...

Read More

Vexing Question on Patient Surveys: Did We Ease Your Pain?

New York Times, August 4, 2016
by Jan Hoffman and Sabrina Tavernise

The questionnaire arrives in the mail a few days after a patient’s discharge from the hospital

..

.

Read More

This Could Have Been The First Poop Pill To Hit The Market, But It Failed Clinical Trials

BuzzFeed Science, July 29, 2016
by Nidhi Subbaraman, quoting Rachel Sachs (Academic Fellow alumna)

[...] “I think it is a big deal,” said Rachel Sachs, a professor of health and law...

Read More

A Trojan Horse?

Ohio State Law Journal, 2017 (forthcoming)
by Christopher T. Robertson (Academic Fellow alumnus)

Abstract:      
; Scholars, advocates, and courts have begun to recogniz...

Read More

Nudging Health: Health Law and Behavioral Economics:

Johns Hopkins University Press, October 2016 (forthcoming)
by I. Glenn Cohen (Faculty Director), Holly Fernandez Lynch (Executive Director), and Christopher T. Robertson (Academic Fellow alumnus), eds.

>Pre-order the book ;here

!

Abstract of the Introduction: 

;

This introductory chapter to the...

Read More

Health Insurance as Innovation Incentive

Jotwell, June 9, 2016
by Amy Monahan, reviewing paper by Rachel E. Sachs (Academic Fellow)

Excerpt from the article

:

In Prizing Insurance: Prescription Drug Insurance as Innovation Incentive...

Read More

The Relationship Between Bioethics and U.S. Health Law:

In The Oxford Handbook of U.S. Healthcare Law, I. Glenn Cohen, Allison K. Hoffman, and William M. Sage, eds., May 2016
by I. Glenn Cohen (Faculty Director)

>Abstract: ;This chapter explores the way bioethics is taught as part of U.S. health law. It begi... Read More

FDA’s Punt on Finalizing the Generic Drug Labeling Rule: Experts Debate

Regulatory Affairs Professionals Society, May 19, 2016
by Zachary Brennan, featuring Rachel E. Sachs (Academic Fellow)

From the article: 

;

Rachel Sachs, JD, an academic fellow at the Petrie-Flom Center for Health L...

Read More

Divided Infringement and the Doctor-Patient Relationship

IP Theory, 2016 (Forthcoming)
by Rachel E. Sachs (Academic Fellow)

>Abstract: ;     
; With its recent en banc decision in Akamai v. Limeligh... Read More

Resolving Reverse-Payment Settlements with the Smoking Gun of Stock Price Movements

81 Iowa Law Review 1581, 2016
by Thomas G. McGuire, Keith Drake, Einer Elhauge (Founding Faculty Director), Raymond S. Hartman, Martha Starr

>Abstract: ;The Supreme Court recently held that in reverse-payment settlements of drug patent di... Read More

What’s next for opioid legislation?

Politico Pulse, April 22, 2016
by Dan Diamond, referencing Rachel E. Sachs (Academic Fellow)

Excerpt from article

:

[...] HEALTH WONK RECAP — PULSE flagged a few interesting stu...

Read More

Prizing Insurance: Prescription Drug Insurance as Innovation Incentive,

Harvard Journal of Law and Technology, Vol. 30, No. 1 (forthcoming)
by Rachel E. Sachs

Abstract: 

;

A problem perennially facing scholars of both intellectual property and health law...

Read More

Promoting Healthcare Innovation on the Demand Side,

U of Michigan Law & Econ Research Paper No. 16-008; U of Michigan Public Law Research Paper No. 503
by Rebecca Eisenberg and W. Nicholson Price II (Academic Fellow Alumnus)

Abstract

:

Innovation policy often focuses on the incentives of firms that sell new products. But op...

Read More

Chinese Market Offers New Life to Many Drugs

Dow Jones Business News, March 29, 2016
by Fanfan Wang, quoting I. Glenn Cohen (Faculty Director)

Excerpt from Article

:

[...] But the new trend also raises the question of whether China has become...

Read More

Ethicist
Trillium Health Partners

Deadline: March 08, 2016

Position: Ethicis

t

Status: Full Tim

e

File#: 2016-449

4

Dept/Health System: Ethic

s

Site: Trillium...

Read More

Fecal Transplants to Treat C. difficile: FDA Seeks Comment on What IND Requirements to Waive

Regulatory Affairs, February 29, 2016
by Zachary Brennan, citing Rachel E. Sachs (Academic Fellow)

From the article: 

;

[...] The draft guidance comes as over the past few years, FMT, which basic...

Read More

New Journal of Law & Biosciences featuring Harvard student work

Journal of Law and the Biosciences (JLB), Vol. 3, Issue 1 (April 2016)

The ;Journal of Law and the Biosciences, the open-access journal launched in 2014 by the Pe...

Read More

How to Make the Most of Drugs We Already Have

The Upshot, New York Times, February 22, 2016
by By Austin Frakt, citing Ben Roin (Academic Fellow alumnus)

From the articl

e

[...] Moreover, if a drug company cannot ascertain the problem for which a prescri...

Read More

Fourth Annual Health Law Year in P/Review

Friday, January 29, 2016 8:00 AM - 5:00 PM
Conferences
2015-2016
Wasserstein Hall, Milstein West AB
Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA

>Couldn't attend in person? Learn more about the event

:
  • Learn more about the presentations -...

Read More

Does it break the law to charge a lot for a cure?

The Incidental Economist Blog, January 28, 2016
by Nicolas Bagley, quoting Rachel E. Sachs (Academic Fellow)

>From the article

:

[...] Talk about sending the wrong signals about what sorts of drugs we value mos...

Read More

“FDA in the 21st Century: A Panel Discussion”:

MAGI, May 2, 2016, 8:30 - 10:00 AM
by Holly Fernandez Lynch (Executive Director) and I. Glenn Cohen (Faculty Director)

On Monday, May 2, 2016, from 8:30 to 10:00am, Petrie-Flom Executive Director Holly Fernandez Lynch a...

Read More

Why Preventing Cancer Is Not the Priority in Drug Development

The Upshot, New York Times, December 28, 2015
by Austin Frakt, citing Ben Roin (former Academic Fellow and Faculty Co-Director)

From the article: 

;

Most people would agree that it would be better to prevent cancer, if...

Read More

How to Decrease Prices for an Expensive Class of Drugs

The New York Times, November 16, 2015
by Austin Frakt, quoting W. Nicholson Price II (Academic Fellow Alumnus)

Excerpt from the article

:

[...] As the law professors W. Nicholson Price and Arti Rai put it,...

Read More

Regulating Secrecy

Washington Law Review, 2015 (Forthcoming)
by W. Nicholson Price II (Academic Fellow Alumnus)

Abstract:      

;


Regulation interacts with intellectual-property excl...

Read More

Salad Days: Professor Jacob Gersen on the rise of food law

Harvard Crimson, September 29, 2015
by Michael Zuckerman, quoting Jacob Gersen (Director, Food Law Lab at the Petrie-Flom Center& Affiliated Faculty)

From the article

:

[...] Much of Harvard Law School now seems hungry to talk about it, too. In addit...

Read More

Heidi Williams wins MacArthur “genius grant”

MIT News, September 29, 2015
by Peter Dizikes, on Heidi Williams (Student Fellow Alumna)

From the article

:

MIT economist Heidi Williams, whose scholarly work looks at the effects of patent...

Read More

How Patent Law Can Block Even Lifesaving Drugs

New York Times, September 28, 2015
by Austin Frakt, quoting Benjamin Roin (Former Faculty Co-Director & Academic Fellow; Current Affiliated Faculty)

From the article

:

To see evidence of this, just look at the behavior of pharmaceutical firms. When...

Read More

How Prescription Drugs Get So Wildly Expensive

WIRED, September 23, 2015
by Nick Stockton, quoting Rachel E. Sachs (Academic Fellow)

From the article

:

[...] With all that in mind, here’s the important question: Is Sh...

Read More

Research Assistants, International Health and Drug Law
Multi-Regional Clinical Trials Center, Brigham & Women's Hospital

Deadline: Open until filled.

The MRCT Center of BWH and Harvard is seeking one or two research assistants for the Multi-Regional...

Read More

FDA in the 21st Century:

Columbia University Press, September 2015
by Holly Fernandez Lynch (Executive Director) and I. Glenn Cohen (Faculty Director), eds.

Just out from Columbia University Press, ;FDA in the Twenty-First Century: The Challenges o...

Read More

Review of Human Subjects Research Regulation: Perspectives on the Future

IRB: Ethics & Human Research, July-August 2015, Vol. 37, No. 4
by Christine Grady

>Christine Grady, MSN, PhD, the chief of the Department of Bioethics in the Clinical Center of the Na...

Read More

Will clinical trial data disclosure reduce incentives to develop new uses of drugs?

Nature Biotechnology, July 2015, Vol. 33, No. 7
by W Nicholson Price II (Academic Fellow alumnus) & Timo Minssen (past Visiting Scholar)

Petrie-Flom Academic Fellow alumnus ;Nicholson Price, now an Assistant Professor at the&nbs...

Read More

More than meets the IRB: On human subjects research and regulation: perspectives on the future

More Than Meets the IRB Podcast , May 2015, No. 11
by Holly F. Lynch (Executive Director), I. Glenn Cohen (Faculty Director), Michael Leary

In this eleventh installment of “More Than Meets the IRB,” we talk with I. Glenn Cohen (...

Read More

Countdown to Cures

The Medicine Maker, June 25th, 2015, Issue #0615
by Stephanie Sutton, quoting Rachel Sachs (Academic Fellow)

From the article: 

;

[...] According to Rachel Sachs, an academic fellow at the Petrie-Flom Cent...

Read More

Fall 2015 Course: Drug Product Liability Litigation
Harvard Law School

Deadline: Waitlist processing will run from Monday, May 18, 2015 through Friday, June 26, 2015.

Drug Product Liability Litigatio

n

Mr. Peter Gross
i Fall 2015 Cours
e Meets: T, W 5:00pm - 7:00p
...

Read More

“Ending Institutional Corruption” conference, May 1-2

Edmond J. Safra Center for Ethics at Harvard University, April 14, 2015

On Friday, May 1, and Saturday, May 2, several Petrie-Flom Center affiliates will participate in the...

Read More

Health Law Workshop: Rachel E. Sachs

Monday, April 13, 2015 5:00 PM
Health Law Workshops
2014-2015
Griswold Hall, Room 110
1525 Massachusetts Ave., Cambridge, MA

>Presentation Title: "Rethinking the Incentives/Access Dichotomy: Prescription Drug Reimbursement as... Read More

Resolving Reverse-Payment Settlements with the Smoking Gun of Stock Price Movements

Iowa Law Review, Vol. 81, No. 4, 2016 Forthcoming
by Thomas G. McGuire, Keith Drake, Einer Elhauge (Founding Faculty Director), Raymond S. Hartman, Martha Starr

Founding Faculty Director ;Einer Elhauge and four co-authors have just posted a new article ...

Read More

Are trade secrets delaying biosimilars?

Science, April 10, 2015
by W. Nicholson Price II (Academic Fellow Alumnus) and Arti K. Rai

Petrie-Flom Academic Fellow alumnus Nicholson Price, now an Assistant Professor at the Uni...

Read More

Robust Exclusion and Market Division Through Loyalty Discounts

Harvard Public Law Working Paper No. 14-12, April 2, 2015
by By Einer Elhauge (Founding Faculty Director) and Abe Wickelgren

Founding Faculty Director Einer Elhauge has coauthored an article Abe Wickelgren on loyalty discount...

Read More